Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Precision Peptide Company Inc (PNGAF)

Precision Peptide Company Inc (PNGAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
The Precision Peptide Company Opens Nationwide Retail Sales Days After FDA Panel Backs Six of Seven Peptides Under Review Newsfile - Thu Jul 30, 6:10AM CDT

HighlightsSeven products are now in stock and available to purchase at precisionpeptidecompany.com: BPC, KPV, Ageless, Chill, Blue, Hair and The Recovery PatchThe Recovery Patch is the Company's first...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Advances First-to-Market Thymosin Alpha-1 Patch for Immune Support Newsfile - Tue Jul 28, 6:10AM CDT

HighlightsQ3/Q4 2026 is the targeted completion period for testing of The Precision Peptide Company's Thymosin Alpha-1 transdermal patch2025 research continues to evaluate Thymosin Alpha-1 for immune regulation...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Applauds FDA Advisory Committee Vote on Expanded Pathway for BPC-157 and KPV Newsfile - Fri Jul 24, 6:10AM CDT

On July 23, 2026, the FDA's Pharmacy Compounding Advisory Committee voted 8-6 (one abstention) to recommend BPC-157 for inclusion on the Section 503A Bulks List.BPC-157 was the first of seven peptides...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch Newsfile - Tue Jul 21, 6:10AM CDT

HighlightsThe Precision Peptide Company's newly launched direct-to-consumer and telehealth platform is now available in all 50 states of the United States.100% U.S.-compounded peptide products are supported...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Inc. Receives 20,000-Unit Production Run of BPC-157 Transdermal Patches Newsfile - Tue Jul 14, 6:08AM CDT

HighlightsReceived full production run of approximately 20,000 BPC-157 transdermal patches, the Company's lead product candidatePatches are manufactured and independently tested in the United StatesMarks...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch Newsfile - Tue Jul 7, 1:52PM CDT

HighlightsThe Precision Peptide Company can now sell its peptide products directly to consumers online across all 50 U.S. states, with its consumer-facing retail telehealth website now liveThe site connects...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company's Needle-Free Recovery Patch Featured in Men's Health Magazine Newsfile - Tue Jun 30, 6:40AM CDT

Vancouver, British Columbia--(Newsfile Corp. - June 30, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Achieves LegitScript Healthcare Merchant Certification Newsfile - Tue Jun 23, 6:40AM CDT

Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Announces Release of The Human Upgrade with Dave Asprey Episode Featuring Chief Scientific Officer Justin Kirkland Newsfile - Tue Jun 16, 6:32AM CDT

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Establishes Compliant U.S. Peptide Access with Telehealth and Prescription Infrastructure Partnership Newsfile - Tue Jun 9, 6:32AM CDT

HighlightsSigned an agreement with a U.S.-based prescription telehealth and infrastructure partner to support compliant prescribing, fulfillment, and delivery of the Company's peptide productsBuilds on...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)

Barchart Exclusives

Wall Street Can’t Agree on Palantir Stock. Earnings Will Reveal Who’s Right. Barchart - 28 minutes ago
Palantir heads into earnings on Aug. 3 with Wall Street divided as bullish growth expectations clash with concerns over commercial demand. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.